Published in Hepatology on August 01, 1993
The mammalian ovary from genesis to revelation. Endocr Rev (2009) 2.31
TGF-β in progression of liver disease. Cell Tissue Res (2011) 2.22
Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest (1995) 1.89
Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci U S A (1994) 1.60
The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol Med (1996) 1.16
Apoptosis. Mol Pathol (2000) 1.10
Tumor necrosis factor-alpha-induced apoptosis in hepatocytes in long-term culture. Am J Pathol (1996) 0.96
Activin betaC and betaE genes are not essential for mouse liver growth, differentiation, and regeneration. Mol Cell Biol (2000) 0.95
BMP4 is a novel paracrine inhibitor of liver regeneration. Am J Physiol Gastrointest Liver Physiol (2012) 0.95
Tob1 is a constitutively expressed repressor of liver regeneration. J Exp Med (2010) 0.92
Activins and activin antagonists in hepatocellular carcinoma. World J Gastroenterol (2008) 0.92
Serum activin A and B levels predict outcome in patients with acute respiratory failure: a prospective cohort study. Crit Care (2013) 0.92
Expression changes of activin A in the development of hepatic fibrosis. World J Gastroenterol (2001) 0.90
Primary hepatocytes and their cultures in liver apoptosis research. Arch Toxicol (2013) 0.88
Apoptosis in human hepatocellular carcinoma and in liver cell dysplasia is correlated with p53 protein immunoreactivity. J Clin Pathol (1997) 0.86
Activin C antagonizes activin A in vitro and overexpression leads to pathologies in vivo. Am J Pathol (2008) 0.84
Activin A, p15INK4b signaling, and cell competition promote stem/progenitor cell repopulation of livers in aging rats. Gastroenterology (2010) 0.83
Activins and follistatins: Emerging roles in liver physiology and cancer. World J Hepatol (2009) 0.82
ErbB1 receptor ligands attenuate the expression of synaptic scaffolding proteins, GRIP1 and SAP97, in developing neocortex. Neuroscience (2005) 0.81
Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration. J Pharmacol Exp Ther (2014) 0.79
Pegylated Interferon-α Modulates Liver Concentrations of Activin-A and Its Related Proteins in Normal Wistar Rat. Mediators Inflamm (2015) 0.78
Virtual High-Throughput Screening To Identify Novel Activin Antagonists. J Med Chem (2015) 0.78
Activin A expression in esophageal carcinoma and its association with tumor aggressiveness and differentiation. Oncol Lett (2015) 0.77
Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma? Br J Cancer (2011) 0.77
Effects of hyperthyroidism on expression of vascular endothelial growth factor (VEGF) and apoptosis in fetal adrenal glands. Eur J Histochem (2015) 0.76
Activin A-Smad Signaling Mediates Connective Tissue Growth Factor Synthesis in Liver Progenitor Cells. Int J Mol Sci (2016) 0.76
Activin A and follistatin in patients with nonalcoholic fatty liver disease. Metabolism (2016) 0.75
Substantial Increases Occur in Serum Activins and Follistatin during Lung Transplantation. PLoS One (2016) 0.75
Clinical and Therapeutic Implications of Follistatin in Solid Tumours. Cancer Genomics Proteomics (2016) 0.75
Effects of the Activin A-Follistatin System on Myocardial Cell Apoptosis through the Endoplasmic Reticulum Stress Pathway in Heart Failure. Int J Mol Sci (2017) 0.75
Endothelial transcription factor KLF2 negatively regulates liver regeneration via induction of activin A. Proc Natl Acad Sci U S A (2017) 0.75
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell self-renewal. Genes Dev (1998) 6.74
Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature (1995) 5.51
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell (1995) 4.13
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest (2001) 3.86
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature (1985) 3.38
Gene conversion involving the pilin structural gene correlates with pilus+ in equilibrium with pilus- changes in Neisseria gonorrhoeae. Cell (1986) 2.98
Piliation control mechanisms in Neisseria gonorrhoeae. Proc Natl Acad Sci U S A (1986) 2.96
Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature (1999) 2.80
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol (1998) 2.77
JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity (1999) 2.74
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther (2005) 2.71
Gonococcal pilin variants in experimental gonorrhea. J Exp Med (1987) 2.62
Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (1995) 2.62
Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev (1999) 2.56
Isolation and characterization of new fission yeast cytokinesis mutants. Genetics (1998) 2.51
Effects of recA mutations on pilus antigenic variation and phase transitions in Neisseria gonorrhoeae. Genetics (1987) 2.39
Pilus- gonococcal variants. Evidence for multiple forms of piliation control. J Exp Med (1985) 2.33
Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology (2000) 2.26
V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2001) 2.19
Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials. Aliment Pharmacol Ther (2014) 2.17
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J Neurochem (2001) 2.14
Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst (2001) 2.12
Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell (1985) 2.10
Prospective comparison treatment of 595-nm pulsed-dye lasers for virgin port-wine stain. Br J Dermatol (2015) 1.96
High rates of primary care and emergency department use among injection drug users in Vancouver. J Public Health (Oxf) (2004) 1.95
Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology (1997) 1.94
Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature (1997) 1.90
Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics (1990) 1.88
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology (1997) 1.78
The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther (2004) 1.76
Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology (2009) 1.76
Brain-specific genes have identifier sequences in their introns. Proc Natl Acad Sci U S A (1984) 1.71
Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type 1 infection. J Virol (1996) 1.70
Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents. J Viral Hepat (2009) 1.69
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation (1998) 1.65
Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med (2001) 1.64
Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan. J Clin Microbiol (2001) 1.63
Review article: the treatment of functional abdominal bloating and distension. Aliment Pharmacol Ther (2011) 1.63
The role of the sid1p kinase and cdc14p in regulating the onset of cytokinesis in fission yeast. EMBO J (2000) 1.62
Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology (2002) 1.61
fMRI-acoustic noise alters brain activation during working memory tasks. Neuroimage (2005) 1.60
Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci U S A (1987) 1.58
Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal neural development, are produced by alternative splicing. Proc Natl Acad Sci U S A (1987) 1.57
Functional GI disorders: from animal models to drug development. Gut (2007) 1.55
Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern. Neurogastroenterol Motil (2013) 1.55
Time course of ADCw changes in ischemic stroke: beyond the human eye! Stroke (1998) 1.54
Serology of Streptococcus sanguis: localization of antigens with unlabeled antisera. Infect Immun (1973) 1.52
Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry (2001) 1.52
Two outbreaks of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Northern California. JAMA (1999) 1.49
Identification of conserved, RpoS-dependent stationary-phase genes of Escherichia coli. J Bacteriol (1998) 1.49
Brain areas specific for attentional load in a motion-tracking task. J Cogn Neurosci (2001) 1.48
Prevalence of sleep-disordered breathing in diastolic heart failure. Chest (1997) 1.47
Gender-related differences in IBS symptoms. Am J Gastroenterol (2001) 1.47
In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci (1996) 1.46
Meige disease: striatal dopaminergic preponderance. Neurology (1979) 1.46
Severity in irritable bowel syndrome: a Rome Foundation Working Team report. Am J Gastroenterol (2011) 1.46
Role of neuregulins in glial cell development. Glia (2000) 1.45
Effects of intravenous IL-8 administration in nonhuman primates. J Immunol (1992) 1.44
Autoantibodies in systemic vasculitis. Aust N Z J Med (1991) 1.44
A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance. J Biol Chem (1999) 1.43
Gene conversion variations generate structurally distinct pilin polypeptides in Neisseria gonorrhoeae. J Exp Med (1987) 1.43
Practice-induced changes of brain function during visual attention: a parametric fMRI study at 4 Tesla. Neuroimage (2004) 1.42
cDNA clones encoding IgE-binding factors from a rat-mouse T-cell hybridoma. Proc Natl Acad Sci U S A (1985) 1.41
Bone mineral density and body composition in patients with airflow obstruction--the role of inhaled steroid therapy, disease and lifestyle. Clin Exp Allergy (1998) 1.39
Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am J Gastroenterol (2000) 1.38
Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses. EMBO J (1995) 1.38
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol (1992) 1.37
Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut (2005) 1.37
Fragmented condensate ground state of trapped weakly interacting bosons in two dimensions. Phys Rev Lett (2001) 1.36
Expression of the receptor protein-tyrosine kinases Tyro-3, Axl, and mer in the developing rat central nervous system. J Comp Neurol (2000) 1.36
Progressive right frontotemporal degeneration: clinical, neuropsychological and SPECT characteristics. Dementia (1993) 1.35
Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology (2001) 1.35
Gender differences in the functional organization of the brain for working memory. Neuroreport (2000) 1.33
An evolutionarily conserved transmembrane protein that is a novel downstream target of neurotrophin and ephrin receptors. J Neurosci (2001) 1.33
Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet (1999) 1.31
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes. J Med Chem (1998) 1.31
Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurology (2001) 1.30
Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology (1997) 1.30
Kinetic analyses of stability of simple and complex retroviral vectors. Virology (2001) 1.28
Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc Natl Acad Sci U S A (1986) 1.28
A post-reconstruction method to correct cupping artifacts in cone beam breast computed tomography. Med Phys (2007) 1.27
Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology (1995) 1.27
A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. Cancer Res (1997) 1.27
Different activation patterns for working memory load and visual attention load. Brain Res (2006) 1.25
Insulin-like growth factor-1 stimulation of lymphopoiesis. J Clin Invest (1993) 1.24
Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutr Diabetes (2011) 1.23
Gender differences in regional brain response to visceral pressure in IBS patients. Eur J Pain (2000) 1.23